Pharmaceuticals, Biotechnology and Life Sciences
SAN FRANCISCO–(BUSINESS WIRE)–Imago BioSciences, Inc., a clinical-stage biotechnology company developing innovative treatments for myeloid diseases, today announced that the U.S.…
Former chief executive officer of Myotonic brings extensive experience in patient advocacy and community engagement WALTHAM, Mass.–(BUSINESS WIRE)–Dyne Therapeutics, a…
– On-Track for First Patient Enrollment in 1Q 2020– –Company to Host R&D Symposium for Investors/Analysts on Tuesday January 14,…
– Recent Non-Dilutive Financing Extends Cash Runway into 2H 2021 and Fully Funds All Ongoing IPI-549 Clinical Trials Through Key…
Waters enables core product portfolio with next-generation automation technology MILFORD, Mass.–(BUSINESS WIRE)–Waters Corporation (NYSE:WAT) announced today that it has entered…
LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that its Chief Executive Officer and President, Alan H.…
TORONTO–(BUSINESS WIRE)–Antibe Therapeutics Inc. (“Antibe” or the “Company”) (TSXV: ATE, OTCQB: ATBPF), a leader in developing safer, non-addictive therapeutics for…
Strategic collaboration to integrate AI technology, drug development expertise and ecosystem of partners for the commercialization of promising early-stage research…
Daré may be entitled to up to $310 million in commercial milestone payments plus tiered royalties on net sales in…
– KVD900 Phase 2 Clinical Trial Data Anticipated in Q2 2020 – – KVD824 Selected for Prophylactic Treatment; Phase 2…